Metyrosine in psychosis associated with 22q11.2 deletion syndrome: case report.

@article{Carandang2007MetyrosineIP,
  title={Metyrosine in psychosis associated with 22q11.2 deletion syndrome: case report.},
  author={Carlo G Carandang and Monique C Scholten},
  journal={Journal of child and adolescent psychopharmacology},
  year={2007},
  volume={17 1},
  pages={115-20}
}
This report describes the use of metyrosine (Demser) in an adolescent male with psychosis associated with the 22q11.2 deletion syndrome (velocardiofacial syndrome; VCFS), diagnosed by fluorescence in situ hybridization (FISH). He presented with multiple features of 22q11.2 deletion syndrome, including ventricular septal defect, palatal abnormalities, speech and motor delays, attention deficits, mood lability, and psychosis. After a failed trial of an atypical antipsychotic to address the… CONTINUE READING